Abstract: Accurate brain tumors segmentation is essential for precise diagnosis, planning, treatment, and monitoring of the tumor. However, the variations in tumor size, shape, and location, ...
Some avid fans of The Thursday Murder Club books took issue when Netflix's movie adaptation was released last month and some certain changes became apparent. While it's no surprise that the film ...
Abstract: Specific emitter identification (SEI) can enhance the recognition of external devices and improve network communications security performance. Although many methods that combine deep and ...
Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™), combined with standard ...
Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies Demonstrated a Significant Improvement in Minimal Residual Disease Negativity ...
PRINCETON, N.J., September 23, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ...
PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BMS--Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an ...
Comey Case Mea Culpa: Statute of Limitations Not Necessarily a Bar to New Indictment If Current One Is Dismissed Comey Case Developments: (5) Motion to Dismiss Based on Illegality of Interim U.S.
Recent studies highlight the potential of minimal residual disease (MRD) testing to influence treatment decisions in multiple myeloma and chronic lymphocytic leukemia. Testing for minimal residual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback